In summary, we have used genetic profiling of inflamed IBD tissue and sensory neurons to identify a novel pathway for visceral nociceptor activation in the inflamed bowel, namely Ang II/AT1–mediated activation of NaV1.8-positive nociceptors. Here, AGT is linked to inflammatory bowel disease.